Cargando…

Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam

BACKGROUND: Detection of ceftazidime/avibactam (CAZ/AVI) antibacterial activity is absolutely vital with the rapid growth of carbapenem resistant Enterobacteriaceae (CRE). But now, there is no available automated antimicrobial susceptibility testing card for CAZ/AVI, so Kirby-Bauer has become an eco...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xianggui, Wang, Dan, Zhou, Qin, Nie, Fang, Du, Hongfei, Pang, Xueli, Fan, Yingzi, Bai, Tingting, Xu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824082/
https://www.ncbi.nlm.nih.gov/pubmed/31675928
http://dx.doi.org/10.1186/s12866-019-1613-5
_version_ 1783464668546727936
author Yang, Xianggui
Wang, Dan
Zhou, Qin
Nie, Fang
Du, Hongfei
Pang, Xueli
Fan, Yingzi
Bai, Tingting
Xu, Ying
author_facet Yang, Xianggui
Wang, Dan
Zhou, Qin
Nie, Fang
Du, Hongfei
Pang, Xueli
Fan, Yingzi
Bai, Tingting
Xu, Ying
author_sort Yang, Xianggui
collection PubMed
description BACKGROUND: Detection of ceftazidime/avibactam (CAZ/AVI) antibacterial activity is absolutely vital with the rapid growth of carbapenem resistant Enterobacteriaceae (CRE). But now, there is no available automated antimicrobial susceptibility testing card for CAZ/AVI, so Kirby-Bauer has become an economical and practical method for detecting CAZ/AVI antibacterial activity against Enterobacteriaceae. RESULT: In this study, antimicrobial susceptibility testing of CAZ/AVI against 386 Enterobacteriaceae (188 Klebsiella pneumoniae, 122 Escherichia coli, 76 Enterobacter cloacae) isolated from clinical patients was performed by broth microdilution. Of the 386 strains, 54 extended spectrum β lactamases negative (ESBL(−)), 104 extended spectrum β lactamases positive (ESBL(+)), 228 CRE. 287 isolates were susceptible to CAZ/AVI and 99 isolates were resistant to CAZ/AVI. At the same time, to obtain optimal content avibactam (AVI) disk containing ceftazidime (30 μg), inhibition zone diameter of four kinds of ceftazidime (30 μg) disk containing different AVI content (0 μg, 10 μg, 25 μg, 50 μg) were tested by Kirby-Bauer method. The microdilution broth method interpretation was used as the standard to estimate susceptible or resistance and then coherence analysis was carried out between Kirby-Bauer and broth microdilution. The result shows the inhibition zone diameter of 30 μg/50 μg disk, susceptible isolates: 20.5 mm–31.5 mm, resistance isolates: 8.25 mm–21.5 mm. The inhibition zone diameter of 30 μg/25 μg disk, susceptible isolates: 19.7 mm–31.3 mm, resistance isolates: 6.5 mm–19.2 mm. The inhibition zone diameter of 30 μg/10 μg disk, susceptible isolates: 19.5 mm–31 mm, resistance isolates: 6.5 mm–11 mm. The inhibition zone diameter of ceftazidime (30 μg), susceptible isolates: 6.5 mm–27.5 mm, resistance isolates 6.5 mm. CONCLUSION: Our results show that 30 μg/50 μg, 30 μg/25 μg, 30 μg/10 μg CAZ/AVI disk have significant statistical differences to determinate CAZ/AVI antibacterial activity, but for 30 μg/50 μg disk, there has a cross section between susceptible isolates (minimum 20.5 mm) and resistance isolates (maximum 21.5 mm). For 30 μg/25 μg disk, it is hard to distinguish the difference between susceptible isolates (minimum 19.7 mm) and resistance isolates (maximum 19.2 mm), so 30 μg/10 μg CAZ/AVI disk is more conducive to determinate antibacterial activity.
format Online
Article
Text
id pubmed-6824082
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68240822019-11-06 Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam Yang, Xianggui Wang, Dan Zhou, Qin Nie, Fang Du, Hongfei Pang, Xueli Fan, Yingzi Bai, Tingting Xu, Ying BMC Microbiol Research Article BACKGROUND: Detection of ceftazidime/avibactam (CAZ/AVI) antibacterial activity is absolutely vital with the rapid growth of carbapenem resistant Enterobacteriaceae (CRE). But now, there is no available automated antimicrobial susceptibility testing card for CAZ/AVI, so Kirby-Bauer has become an economical and practical method for detecting CAZ/AVI antibacterial activity against Enterobacteriaceae. RESULT: In this study, antimicrobial susceptibility testing of CAZ/AVI against 386 Enterobacteriaceae (188 Klebsiella pneumoniae, 122 Escherichia coli, 76 Enterobacter cloacae) isolated from clinical patients was performed by broth microdilution. Of the 386 strains, 54 extended spectrum β lactamases negative (ESBL(−)), 104 extended spectrum β lactamases positive (ESBL(+)), 228 CRE. 287 isolates were susceptible to CAZ/AVI and 99 isolates were resistant to CAZ/AVI. At the same time, to obtain optimal content avibactam (AVI) disk containing ceftazidime (30 μg), inhibition zone diameter of four kinds of ceftazidime (30 μg) disk containing different AVI content (0 μg, 10 μg, 25 μg, 50 μg) were tested by Kirby-Bauer method. The microdilution broth method interpretation was used as the standard to estimate susceptible or resistance and then coherence analysis was carried out between Kirby-Bauer and broth microdilution. The result shows the inhibition zone diameter of 30 μg/50 μg disk, susceptible isolates: 20.5 mm–31.5 mm, resistance isolates: 8.25 mm–21.5 mm. The inhibition zone diameter of 30 μg/25 μg disk, susceptible isolates: 19.7 mm–31.3 mm, resistance isolates: 6.5 mm–19.2 mm. The inhibition zone diameter of 30 μg/10 μg disk, susceptible isolates: 19.5 mm–31 mm, resistance isolates: 6.5 mm–11 mm. The inhibition zone diameter of ceftazidime (30 μg), susceptible isolates: 6.5 mm–27.5 mm, resistance isolates 6.5 mm. CONCLUSION: Our results show that 30 μg/50 μg, 30 μg/25 μg, 30 μg/10 μg CAZ/AVI disk have significant statistical differences to determinate CAZ/AVI antibacterial activity, but for 30 μg/50 μg disk, there has a cross section between susceptible isolates (minimum 20.5 mm) and resistance isolates (maximum 21.5 mm). For 30 μg/25 μg disk, it is hard to distinguish the difference between susceptible isolates (minimum 19.7 mm) and resistance isolates (maximum 19.2 mm), so 30 μg/10 μg CAZ/AVI disk is more conducive to determinate antibacterial activity. BioMed Central 2019-11-01 /pmc/articles/PMC6824082/ /pubmed/31675928 http://dx.doi.org/10.1186/s12866-019-1613-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yang, Xianggui
Wang, Dan
Zhou, Qin
Nie, Fang
Du, Hongfei
Pang, Xueli
Fan, Yingzi
Bai, Tingting
Xu, Ying
Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam
title Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam
title_full Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam
title_fullStr Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam
title_full_unstemmed Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam
title_short Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam
title_sort antimicrobial susceptibility testing of enterobacteriaceae: determination of disk content and kirby-bauer breakpoint for ceftazidime/avibactam
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824082/
https://www.ncbi.nlm.nih.gov/pubmed/31675928
http://dx.doi.org/10.1186/s12866-019-1613-5
work_keys_str_mv AT yangxianggui antimicrobialsusceptibilitytestingofenterobacteriaceaedeterminationofdiskcontentandkirbybauerbreakpointforceftazidimeavibactam
AT wangdan antimicrobialsusceptibilitytestingofenterobacteriaceaedeterminationofdiskcontentandkirbybauerbreakpointforceftazidimeavibactam
AT zhouqin antimicrobialsusceptibilitytestingofenterobacteriaceaedeterminationofdiskcontentandkirbybauerbreakpointforceftazidimeavibactam
AT niefang antimicrobialsusceptibilitytestingofenterobacteriaceaedeterminationofdiskcontentandkirbybauerbreakpointforceftazidimeavibactam
AT duhongfei antimicrobialsusceptibilitytestingofenterobacteriaceaedeterminationofdiskcontentandkirbybauerbreakpointforceftazidimeavibactam
AT pangxueli antimicrobialsusceptibilitytestingofenterobacteriaceaedeterminationofdiskcontentandkirbybauerbreakpointforceftazidimeavibactam
AT fanyingzi antimicrobialsusceptibilitytestingofenterobacteriaceaedeterminationofdiskcontentandkirbybauerbreakpointforceftazidimeavibactam
AT baitingting antimicrobialsusceptibilitytestingofenterobacteriaceaedeterminationofdiskcontentandkirbybauerbreakpointforceftazidimeavibactam
AT xuying antimicrobialsusceptibilitytestingofenterobacteriaceaedeterminationofdiskcontentandkirbybauerbreakpointforceftazidimeavibactam